News Data keeps Lilly in race for new migraine treatment Company still in race to develop CGRP inhibitor for migraine.
Events Partner Content Data Integrity for Clinical Research Summit Data Integrity for Clinical Research Summit
News Valeant's Siliq price undercuts rivals to offset black box w... Siliq will be cheaper than rivals from Novartis and Eli Lilly.
News NHS proposes crackdown on erectile dysfunction drugs and sun... Eli Lilly's Cialis named on list of drugs no longer consider cost-effective.
News Novartis cues up Cosentyx as disease-modifying treatment for... Pharma begins early intervention trial after Cosentyx shows "disease modifying" properties
Oncology Getting predictive technologies to patients, with Concr Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
